Literature DB >> 15345265

Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene.

R McD Young1, B R Lawford, A Nutting, E P Noble.   

Abstract

Substance misuse is influenced by multiple genetic and environmental factors. Recent research has identified a number of potential genetic markers of risk and those associated with drug reward substrates show particular promise. The current study reexamines the extant published data of the association between the D2 dopamine receptor (DRD2) gene minor Taq 1A (A1) allele and substance misuse risk. A series of meta-analyses was performed on 64 studies examining DRD2 A1+ allelic status and substance misuse. In addition, personality was examined as a possible endophenotype. Significant association was found between the A1 allele and severe substance dependence in both Caucasian and non-Caucasian groups. The data did not support a significant association between the A1 allele and personality features. While the specific mechanism underlying these associations requires further elucidation, this genetic marker shows promise as a marker of brain reinforcement processes. Possible ways of utilising the A1 allele to inform prevention and treatment initiatives are discussed. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345265     DOI: 10.1016/j.addbeh.2004.06.012

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  27 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  A research agenda for assessing the potential contribution of genomic medicine to tobacco control.

Authors:  Wayne D Hall
Journal:  Tob Control       Date:  2007-02       Impact factor: 7.552

Review 3.  Ten good reasons to consider biological processes in prevention and intervention research.

Authors:  Theodore P Beauchaine; Emily Neuhaus; Sharon L Brenner; Lisa Gatzke-Kopp
Journal:  Dev Psychopathol       Date:  2008

4.  Association of dopamine receptor gene polymorphism and psychological personality traits in liability for opioid addiction.

Authors:  Nermana Mehić-Basara; Lilijana Oruč; Lejla Kapur-Pojskić; Jasmin Ramić
Journal:  Bosn J Basic Med Sci       Date:  2013-08       Impact factor: 3.363

Review 5.  Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint?

Authors:  Joseph Frascella; Marc N Potenza; Lucy L Brown; Anna Rose Childress
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

6.  The association between perinatal hypoxia exposure and externalizing symptoms and children's decision making in conditions of uncertainty is moderated by DRD2 genotype.

Authors:  Roisin White; Lisa M Gatzke-Kopp; Patrick J Ryan; David M Lydon-Staley
Journal:  Dev Psychobiol       Date:  2018-09-27       Impact factor: 3.038

Review 7.  Candidate gene-environment interaction research: reflections and recommendations.

Authors:  Danielle M Dick; Arpana Agrawal; Matthew C Keller; Amy Adkins; Fazil Aliev; Scott Monroe; John K Hewitt; Kenneth S Kendler; Kenneth J Sher
Journal:  Perspect Psychol Sci       Date:  2015-01

8.  Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.

Authors:  Zsofia Nemoda; Karlen Lyons-Ruth; Anna Szekely; Eszter Bertha; Gabor Faludi; Maria Sasvari-Szekely
Journal:  Behav Brain Funct       Date:  2010-01-12       Impact factor: 3.759

9.  Cortical NMDA receptor expression in human chronic alcoholism: influence of the TaqIA allele of ANKK1.

Authors:  Justin P Ridge; Peter R Dodd
Journal:  Neurochem Res       Date:  2009-03-13       Impact factor: 3.996

10.  Haplotype frequencies at the DRD2 locus in populations of the East European Plain.

Authors:  Olga V Flegontova; Andrey V Khrunin; Olga I Lylova; Larisa A Tarskaia; Victor A Spitsyn; Alexey I Mikulich; Svetlana A Limborska
Journal:  BMC Genet       Date:  2009-09-30       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.